Evidence map›Paper›PMID 35276802›Full record

ArticleNutrients2022

Deprescribing Leads to Improved Energy Intake among Hospitalized Older Sarcopenic Adults with Polypharmacy after Stroke.

Ayaka Matsumoto, Yoshihiro Yoshimura, Hidetaka Wakabayashi, Eiji Kose, Fumihiko Nagano, Takahiro Bise, Yoshifumi Kido, Sayuri Shimazu, Ai Shiraishi

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ayaka MatsumotoDepartment of Pharmacy, Kumamoto Rehabilitation Hospital, Kumamoto 869-1106, Japan.
Yoshihiro YoshimuraCenter for Sarcopenia and Malnutrition Research, Kumamoto Rehabilitation Hospital, Kumamoto 869-1106, Japan.ORCID 0000-0001-7545-4179
Hidetaka WakabayashiDepartment of Rehabilitation Medicine, Tokyo Women's Medical University Hospital, Tokyo 162-8666, Japan.ORCID 0000-0002-0364-0818
Eiji KoseDepartment of Pharmacy, Teikyo University School of Medicine University Hospital, Tokyo 173-8606, Japan.ORCID 0000-0002-5094-2122
Fumihiko NaganoDepartment of Rehabilitation, Kumamoto Rehabilitation Hospital, Kumamoto 869-1106, Japan.
Takahiro BiseDepartment of Rehabilitation, Kumamoto Rehabilitation Hospital, Kumamoto 869-1106, Japan.
Yoshifumi KidoDepartment of Rehabilitation, Kumamoto Rehabilitation Hospital, Kumamoto 869-1106, Japan.
Sayuri ShimazuDepartment of Nutritional Management, Kumamoto Rehabilitation Hospital, Kumamoto 869-1106, Japan.
Ai ShiraishiDepartment of Dental Office, Kumamoto Rehabilitation Hospital, Kumamoto 869-1106, Japan.
Kumamoto City Hospital · JPTeikyo University Hospital · JPTokyo Women's Medical University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence is scarce regarding the polypharmacy in patients with sarcopenia. The aim of this study was to investigate the effect of deprescribing for polypharmacy on the improvement of nutritional intake and sarcopenia in older patients with sarcopenia. A retrospective cohort study was conducted with hospitalized older patients with sarcopenia undergoing rehabilitation after stroke. Study outcomes included energy intake, protein intake, handgrip strength (HG) and skeletal muscle mass index (SMI) at hospital discharge. To consider the effects of deprescribing for polypharmacy, we used multivariate analyses to examine whether the change in the number of medications during hospitalization was associated with outcomes. Of 361 patients after enrollment, 91 (mean age 81.0 years, 48.4% male) presented with sarcopenia and polypharmacy and were eligible for analysis. The change in the number of medications was independently associated with energy intake (β = -0.237,

Indexed as

DeprescriptionsSarcopeniaStrokeAdultAgedAged, 80 and overEnergy IntakeFemaleHand StrengthHospitalizationHumansMalePolypharmacyRetrospective Studiesdeprescribingpolypharmacyrehabilitation nutritionrehabilitation pharmacotherapysarcopenia

Identifiers

PMID35276802
PMCPMC8838977
OpenAlexW4205966226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.